ResearcherStony Brook UniversityNo recent work listed
Jin Wang
Matched on ORCID iD 0000-0002-2841-4913; OpenAlex author ID A5100346147. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 3 papers
Papers 8
- Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance of Fe3O4@polydopamine nanocomposites. Co-author DOI 10.1186/s12951-022-01289-w↗
- Targeting KRAS in PDAC: A New Way to Cure It? Last author DOI 10.3390/cancers14204982↗
- Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future. Last author DOI 10.3390/ijms232315031↗
- Functionalized Graphene@Gold Nanostar/Lipid for Pancreatic Cancer Gene and Photothermal Synergistic Therapy under Photoacoustic/Photothermal Imaging Dual-Modal… Last author DOI 10.1002/smll.202003707↗
- Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer. Last author DOI 10.18632/oncotarget.24025↗
- Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling. Last author DOI 10.1371/journal.pone.0155874↗
- A small-molecule induces apoptosis and suppresses metastasis in pancreatic cancer cells. Co-author DOI 10.1016/j.ejps.2012.12.023↗
- Selective induction of apoptosis: promising therapy in pancreatic cancer. Last author DOI 10.2174/1381612811319120013↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zuojia Liu · 6 shared papers, 2013–2022 · strength 0.77
- Paper Targeting KRAS in PDAC: A New Way to Cure It? DOI 10.3390/cancers14204982↗
- Paper Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future. DOI 10.3390/ijms232315031↗
- Paper Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer. DOI 10.18632/oncotarget.24025↗
- Erkang Wang · 5 shared papers, 2013–2022 · strength 0.45
- Paper Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance… DOI 10.1186/s12951-022-01289-w↗
- Paper Functionalized Graphene@Gold Nanostar/Lipid for Pancreatic Cancer Gene and Photothermal Synergistic Therapy under Photo… DOI 10.1002/smll.202003707↗
- Paper Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling. DOI 10.1371/journal.pone.0155874↗
- Dan Li · 4 shared papers, 2013–2022 · strength 0.37
- Paper Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance… DOI 10.1186/s12951-022-01289-w↗
- Paper Functionalized Graphene@Gold Nanostar/Lipid for Pancreatic Cancer Gene and Photothermal Synergistic Therapy under Photo… DOI 10.1002/smll.202003707↗
- Paper Selective induction of apoptosis: promising therapy in pancreatic cancer. DOI 10.2174/1381612811319120013↗
- Xiuna Jia · 2 shared papers, 2020–2022 · strength 0.28
- Paper Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance… DOI 10.1186/s12951-022-01289-w↗
- Paper Functionalized Graphene@Gold Nanostar/Lipid for Pancreatic Cancer Gene and Photothermal Synergistic Therapy under Photo… DOI 10.1002/smll.202003707↗
- Yuling Wang · 2 shared papers, 2020–2022 · strength 0.28
- Paper Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance… DOI 10.1186/s12951-022-01289-w↗
- Paper Functionalized Graphene@Gold Nanostar/Lipid for Pancreatic Cancer Gene and Photothermal Synergistic Therapy under Photo… DOI 10.1002/smll.202003707↗
- Qianyu He · 1 shared paper, 2022 · strength 0.26
- Xunzhe Yin · 1 shared paper, 2022 · strength 0.22
- Chang Li · 1 shared paper, 2022 · strength 0.22
- Qing Dong · 1 shared paper, 2022 · strength 0.16
- Xiaoyu Guo · 1 shared paper, 2018 · strength 0.12
- Na Guo · 1 shared paper, 2016 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.